Hospital

Previous studies have shown that individuals living with HIV are at higher risk for heart disease than individuals without HIV

Roughly one-third of patients with cancer do not achieve adequate pain control.

The authors emphasize that these findings suggest a need for targeted resources that help reduce boarding and promote equitable access to care.

Extended treatment with high doses of cisplatin-based chemotherapy is associated with severe and progressive hearing loss.

The RECTIFIER framework was able to screen patients with heart failure more accurately and with a cheaper cost than traditional screening methods.

In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.

Older adults who take aspirin for primary prevention of cardiovascular disease are at an increased risk of bleeding.

Treatment often involves a complex daily routine of reconstitution and subcutaneous injection, along with strict storage requirements.

The American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.

Pulsed field ablation may offer patients an efficacious treatment option with limited damage to surrounding tissues.

By developing the Shizuoka score, which features a new predictive model using machine learning, patients with Kawasaki disease who are non-responders to intravenous immunoglobulin were able to be accurately identified.

Researchers identify significant proteins involved in the growth and survival of malignant multiple myeloma cells.

Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.

The ACIP recommendations are designed to improve access to RSV vaccination, emphasizing the need to get vaccinated.

This narrative review dispels the long-held belief that reduction in salt intake leads to better health outcomes in patients with heart failure.

Antibody-drug conjugates (ADCs) revolutionize cancer therapy by delivering powerful drugs directly to tumors and minimize damage to healthy cells.

The UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.

Explore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.

As dupilumab garners positive clinical trial results in patients with chronic obstructive pulmonary disease, it is increasingly important that pharmacists educate themselves on the treatment.

The test can be performed in settings that operate under the Clinical Laboratory Improvement Amendments waiver, including community pharmacies.

Palliative care may help reduce symptoms and improve quality-of-life for patients with cardiovascular disease.

Omar Nadeem, MD, discusses positive outcomes associated with GPRC5D-targeted CAR T-cell therapy.

Validating language proficiency in bilingual pharmacists is crucial for patient safety and communication.

The results are promising for patients with relapsed or refractory follicular lymphoma and diffuse large B-cell lymphoma, and the trial is ongoing to assess the efficacy of odronextamab in other subtypes.

By taking a research-based approach, clinical trials can become more diverse and better serve the needs of all individuals.

Chimeric antigen receptor (CAR) T-cell therapy can engineer T cells to target malignant cells in multiple myeloma.

The findings suggest that exploring gender identity is a normal part of adolescent development for some youths.

The committee, after being presented evidence by the working group, recommended the vaccine for adults aged 65 and older and those 19 or older who have current recommendations to receive a pneumococcal vaccine.

In a rare case of non-tumor anti-Tr/DNER antibody-associated ataxia, the patient is treated with plasmapheresis and intravenous immunoglobulin (IVIG) for symptoms such as dysarthria and difficulty walking.

The designation was approved based on interim data from a phase 1 study that assessed SV-102 among males with metastatic castrate-resistant prostate cancer (mCRPC).